Lauria, Fabio
Bernabò, Paola
Tebaldi, Toma http://orcid.org/0000-0002-0625-1631
Groen, Ewout Joan Nicolaas http://orcid.org/0000-0002-2330-9444
Perenthaler, Elena http://orcid.org/0000-0002-8286-0682
Maniscalco, Federica
Rossi, Annalisa http://orcid.org/0000-0001-8750-4575
Donzel, Deborah
Clamer, Massimiliano
Marchioretto, Marta
Omersa, Neža http://orcid.org/0000-0003-3889-7645
Orri, Julia
Dalla Serra, Mauro http://orcid.org/0000-0003-1048-2739
Anderluh, Gregor
Quattrone, Alessandro
Inga, Alberto
Gillingwater, Thomas Henry http://orcid.org/0000-0002-0306-5577
Viero, Gabriella http://orcid.org/0000-0002-6755-285X
Funding for this research was provided by:
Fondazione Cassa Di Risparmio Di Trento E Rovereto (young Post-doc funding grant)
European Cooperation in Science and Technology (CA15126)
Javna Agencija za Raziskovalno Dejavnost RS (P1-0391)
Wellcome Trust (106098/Z/14/Z)
Provincia Autonoma di Trento (AxonomiX)
AFM-Téléthon (22129)
Fondazione Telethon (GGP19115)
Article History
Received: 29 August 2019
Accepted: 13 August 2020
First Online: 21 September 2020
Competing interests
: M.C. is the CEO of IMMAGINA Biotechnology; G.V. is a scientific advisor to IMMAGINA Biotechnology; T.H.G. has served on SMA advisory boards for Roche. The other authors declare no competing interests.